Medifast Sees Q3 GAAP EPS $(0.65)-$(0.15) vs $(0.62) Est; Sees Sales $60.000M-$80.000M vs $67.700M Est

Benzinga Newsdesk www.benzinga.com Neutral 48.4%

Neg 0% Neu 48.4% Pos 0%

Medifast (NYSE:MED) is looking for Q3 GAAP EPS of $(0.65)-$(0.15) vs $(0.62) analyst estimate. sees sales of $60.000 million-$80.000 million vs $67.700 million analyst estimate.